Redefining preclinical testing: human-relevant alternatives beyond animal models
BMB Reports · 31.07.2026 · 59 (7) · 341-348
DOI: 10.5483/bmbrep.2025-0078 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMB Reports, erschienen am 31.07.2026. Verfasst von Jieun Jang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Food and Drug Safety, National Research Council of Science and Technology, Aging Con vergence Research Center.
Abstract (Originalsprache)
Both ethical imperatives and scientific limitations increasingly challenge the traditional reliance on animal models for toxicity testing and drug evaluation, particularly in the era of precision medicine. In response, a paradigm shift is underway, marked by the development of advanced in vitro and in silico technologies that can offer human-relevant and mechanistically informed alternatives. This review examines well-established alternatives, such as receptor binding assays, the monocyte activation test, and enzyme-linked immunosorbent assays, highlighting their applications, mechanisms, and limitations. We further explore emerging human-relevant technologies that include organoids, organ-on-a-chip systems, microphysiological systems, and artificial intelligence-powered modeling platforms. Special emphasis is placed on immune-integrated microphysiological systems as next-generation platforms to evaluate immunotherapy, vaccine responses, and immune toxicities. These models recapitulate dynamic human physiological processes, such as hematopoiesis and germinal center reactions, beyond the capabilities of traditional animal systems. Collectively, these technologies represent scientifically superior and ethically progressive trajectories for preclinical testing. Their integration into regulatory and industrial workflows requires continued refinement, cross-sector collaboration, and standardization.
Förderung
- Ministry of Food and Drug Safety
- National Research Council of Science and Technology
- Aging Con vergence Research Center
- National Research Foundation of Korea
Zitieren
APA
Jang, J., Yang, W., Jeong, H., Lee, N., Park, J., Kim, W., Cha, B., Yoon, S., Noh, J., & Lee, J. (2026). Redefining preclinical testing: human-relevant alternatives beyond animal models. BMB Reports, 59(7), 341-348. https://doi.org/10.5483/bmbrep.2025-0078
Vancouver
Jang J, Yang W, Jeong H, Lee N, Park J, Kim W, et al. Redefining preclinical testing: human-relevant alternatives beyond animal models. BMB Reports. 2026;59(7):341-348. doi:10.5483/bmbrep.2025-0078
BibTeX
@article{Jang2026,
author = {Jang, Jieun and Yang, Wonjun and Jeong, Hanseul and Lee, Nam-Kyung and Park, Jong-Gil and Kim, Wantae and Cha, Boksik and Yoon, Sung-Jin and Noh, Ji-Yoon and Lee, Jangwook},
title = {Redefining preclinical testing: human-relevant alternatives beyond animal models},
journal = {BMB Reports},
year = {2026},
volume = {59},
number = {7},
pages = {341--348},
doi = {10.5483/bmbrep.2025-0078}
}
EUVIMED